Chemical inhibition of AIMP2-DX2 and HSP70 interaction successfully decreases AIMP2-DX2 levels in cells and induces tumor regression in an in vivo mouse model, suggesting the interface of AIMP2-DX2 and HSP70 as a novel target to control cancer. This evidence concerns the gene AIMP2 and neoplasm.